Healthcare

• Cochlear (ASX:COH) closed at A$154.44, gaining 8.65%, following full-year results that came in at the upper end of revised guidance.

• Australian Clinical Labs (ASX:ACL) closed at A$3.20, gaining 0.95%, as the company continues its operations within Australia's pathology services market.

• 4DMedical (ASX:4DX) closed at A$2.41, gaining 12.09%, following its Q1 FY27 quarterly activity report highlighting growingRevenuetraction.

• Ryman Healthcare (ASX:RYM) closed flat at A$1.435, unchanged on the session, amid ongoingBalance Sheetmanagement efforts.

• Mesoblast (ASX:MSB) closed at A$2.17, up 3.33%, as the company reported a 44% increase in net revenues and an 86% improvement in net operational cash spend.

• Clarity Pharmaceuticals (ASX:CU6) closed at A$1.60, surging 15.94%, following its quarterly activity report for the September 2026 quarter.

• Sigma Healthcare (ASX:SIG) closed at A$2.82, gaining 1.08%, as the company continues to progress its operations within Australia's pharmaceutical distribution market.